Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Wachowicz, Katarzyna ^a   Hermann Kleiter, Natascha ^a   Meisel, Marlies ^a,b   Siegmund, Kerstin ^a   Thuille, Nikolaus ^a   Baier, Gottfried ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 23; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN KINASE C; STAT4 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; INTERLEUKIN 17; ISOENZYME; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT; PRKCQ PROTEIN, MOUSE; STAT1 PROTEIN; STAT1 PROTEIN, MOUSE; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; GENE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TH17 CELL; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; DEFICIENCY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL;

ANIMALS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; ISOENZYMES; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; PHENOTYPE; PHOSPHORYLATION; PROTEIN KINASE C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH17 CELLS;

EID: 84900441078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096401     Document Type: Article

References (53)

1. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3502616&tool= pmcentrez&rendertype=abstract. Accessed 2013 July 30.
2. Kanno Y, Vahedi G, Hirahara K, Singleton K, O'Shea JJ (2012) Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 30: 707-731. Available: http://www.annualreviews.org/doi/full/10.1146/annurev-immunol-020711- 075058?url-ver=Z39.88-2003&rfr-id=ori:rid:crossref.org&rfr-dat=cr-pub= pubmed&. Accessed 2013 August 12.
3. Muranski P, Restifo NP (2013) Essentials of Th17 cell commitment and plasticity. Blood 121: 2402-2414. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 23325835. Accessed 2013 May 27.
4. Basu R, Hatton RD, Weaver CT (2013) The Th17 family: flexibility follows function. Immunol Rev 252: 89-103. Available: http://doi.wiley.com/10.1111/imr. 12035. Accessed 2013 August 8.
5. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. Available: http://www.ncbi.nlm.nih.gov/pubmed/16473830. Accessed 2013 August 15.
6. Kurschus FC, Croxford AL, Heinen AP, Wörtge S, Ielo D, et al. (2010) Genetic proof for the transient nature of the Th17 phenotype. Eur J Immunol 40: 3336-3346. Available: http://www.ncbi.nlm.nih.gov/pubmed/21110317. Accessed 2013 June 24.
7. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, et al. (2011) Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12: 255-263. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3040235&tool=pmcentrez&rendertype=abstract. Accessed 2013 May 21.
8. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, et al. (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30: 92-107. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3607320&tool=pmcentrez&rendertype=abstract. Accessed 2013 May 31.
9. Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, et al. (2010) Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33: 279-288. Available: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3078329&tool=pmcentrez&rendertype=abstract. Accessed 2013 August 20.
10. Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, et al. (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=2442746&tool=pmcentrez&rendertype=abstract. Accessed 2013 August 8.
11. Martin-Orozco N, Chung Y, Chang SH, Wang Y-H, Dong C (2009) Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39: 216-224. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2755057&tool=pmcentrez&rendertype=abstract. Accessed 2013 October 14.
12. Mukasa R, Balasubramani A, Lee YK, Whitley SK, Weaver BT, et al. (2010) Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32: 616-627. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3129685&tool= pmcentrez&rendertype=abstract. Accessed 2013 August 31.
13. Isakov N, Altman A (2012) PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors. Front Immunol 3: 273. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3425079&tool= pmcentrez&rendertype=abstract. Accessed 2013 October 15.
14. Pfeifhofer C, Kofler K, Gruber T, Tabrizi NG, Lutz C, et al. (2003) Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J Exp Med 197: 1525-1535. Available: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=2193906&tool= pmcentrez&rendertype=abstract. Accessed 2013 July 2.
15. Marsland BJ, Nembrini C, Schmitz N, Abel B, Krautwald S, et al. (2005) Innate signals compensate for the absence of PKC-{theta} during in vivo CD8(+) T cell effector and memory responses. Proc Natl Acad Sci U S A 102: 14374-14379. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 1242314&tool=pmcentrez&rendertype=abstract. Accessed 2013 September 6.
16. Salek-Ardakani S, So T, Halteman BS, Altman A, Croft M (2004) Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C theta. J Immunol 173: 6440-6447. Available: http://www.ncbi.nlm.nih. gov/pubmed/15528385. Accessed 2013 September 6.
17. Marsland BJ, Soos TJ, Späth G, Littman DR, Kopf M (2004) Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J Exp Med 200: 181-189. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2212016&tool= pmcentrez&rendertype=abstract. Accessed 2013 July 2.
18. Zhang EY, Kong K-F, Altman A (2013) The yin and yang of protein kinase C-theta (PKCh): a novel drug target for selective immunosuppression. Adv Pharmacol 66: 267-312. Available: http://www.ncbi.nlm.nih.gov/pubmed/23433459. Accessed 2013 October 21.
19. Hermann-Kleiter N, Gruber T, Lutz-Nicoladoni C, Thuille N, Fresser F, et al. (2008) The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity 29: 205-216. Available: http://dx.doi.org/10.1016/j.immuni.2008.06.008. Accessed 2013 June 20.
20. Schulz EG, Mariani L, Radbruch A, Höfer T (2009) Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. Immunity 30: 673-683. Available: http://www.ncbi.nlm.nih. gov/pubmed/19409816. Accessed 2013 June 4.
21. Zhu J, Jankovic D, Oler AJ, Wei G, Sharma S, et al. (2012) The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37: 660-673. Available: http://www.ncbi.nlm.nih.gov/pubmed/23041064. Accessed 2013 May 31.
22. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, et al. (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282: 9358-9363. Available: http://www.jbc.org/content/282/13/9358.abstract? ijkey=1ddc36aa6d48447a2f4d1e4577a93e3dd151a816&keytype2=tf-ipsecsha. Accessed 2013 May 30.
23. Lin JT, Martin SL, Xia L, Gorham JD (2005) TGF-{beta}1 Uses Distinct Mechanisms to Inhibit IFN-{gamma} Expression in CD4 + T Cells at Priming and at Recall: Differential Involvement of Stat4 and T-bet. J Immunol 174: 5950-5958. Available: http://www.jimmunol.org/content/174/10/5950.long. Accessed 2013 July 3.
24. Santarlasci V, Maggi L, Capone M, Frosali F, Querci V, et al. (2009) TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol 39: 207-215. Available: http://www.ncbi.nlm.nih.gov/ pubmed/19130583.
25. Meisel M, Hermann-Kleiter N, Hinterleitner R, Gruber T, Wachowicz K, et al. (2013) The kinase PKCa selectively upregulates interleukin-17A during Th17 cell immune responses. Immunity 38: 41-52. Available: http://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=3556779&tool=pmcentrez&rendertype= abstract. Accessed 2013 June 6.
26. Kastelein RA, Hunter CA, Cua DJ (2007) Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25: 221-242. Available: http://www.annualreviews.org/doi/full/10.1146/ annurev.immunol.22.012703.104758?url-ver=Z39.88-2003&rfr-id=ori:rid: crossref.org&rfr-dat=cr-pub=pubmed. Accessed 2013 May 23.
27. Lupov IP, Voiles L, Han L, Schwartz A, De La Rosa M, et al. (2011) Acquired STAT4 deficiency as a consequence of cancer chemotherapy. Blood 118: 6097-6106. Available: http://bloodjournal.hematologylibrary.org/content/118/23/ 6097.long. Accessed 3 July 2013.
28. Shin H-J, Park H-Y, Jeong S-J, Park H-W, Kim Y-K, et al. (2005) STAT4 Expression in Human T Cells Is Regulated by DNA Methylation but Not by Promoter Polymorphism. J Immunol 175: 7143-7150. Available: http://www.jimmunol.org/ content/175/11/7143.long. Accessed 2013 July 3.
29. Tanaka T, Soriano MA, Grusby MJ (2005) SLIM Is a Nuclear Ubiquitin E3 Ligase that Negatively Regulates STAT Signaling. Immunity 22: 729-736. Available: http://dx.doi.org/10.1016/j.immuni.2005.04.008. Accessed 2013 July 3.
30. Newton AC (2010) Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 298: E395-402. Available: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2838521&tool=pmcentrez&rendertype=abstract. Accessed 2013 September 20.
31. Tan S-L, Zhao J, Bi C, Chen XC, Hepburn DL, et al. (2006) Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J Immunol 176: 2872-2879. Available: http://www.ncbi.nlm.nih.gov/pubmed/16493044. Accessed 2013 July 2.
32. Salek-Ardakani S, So T, Halteman BS, Altman A, Croft M (2005) Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis. J Immunol 175: 7635-7641. Available: http://www.ncbi.nlm.nih.gov/pubmed/16301673. Accessed 2013 July 2.
33. Kwon M-J, Ma J, Ding Y, Wang R, Sun Z (2012) Protein kinase C-h promotes Th17 differentiation via upregulation of Stat3. J Immunol 188: 5887-5897. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3484892&tool=pmcentrez&rendertype=abstract. Accessed 2013 June 6.
34. Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, et al. (2000) PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404: 402-407. Available: http://www.ncbi.nlm.nih. gov/pubmed/10746729. Accessed 2013 July 2.
35. McVicar DW, Winkler-Pickett R, Taylor LS, Makrigiannis A, Bennett M, et al. (2002) Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J Immunol 169: 1721-1728. Available: http://www.jimmunol.org/content/169/4/1721.full. Accessed 2013 October 3.
36. Mittleman BB, Morse HC, Payne SM, Shearer GM, Mozes E (1996) Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection. J Clin Immunol 16: 230-236. Available: http://www.ncbi.nlm.nih.gov/pubmed/8840225. Accessed 2013 October 3.
37. Lee S-U, Grigorian A, Pawling J, Chen I-J, Gao G, et al. (2007) N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration. J Biol Chem 282: 33725-33734. Available: http://www.jbc.org/ content/282/46/33725.full. Accessed 2013 October 3.
38. Nishanth G, Sakowicz-Burkiewicz M, Händel U, Kliche S, Wang X, et al. (2010) Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta. Infect Immun 78: 3454-3464. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2916261&tool=pmcentrez&rendertype=abstract. Accessed 2013 September 27.
39. Gruber T, Hermann-Kleiter N, Pfeifhofer-Obermair C, Lutz-Nicoladoni C, Thuille N, et al. (2009) PKC theta cooperates with PKC alpha in alloimmune responses of T cells in vivo. Mol Immunol 46: 2071-2079. Available: http://www.ncbi.nlm.nih.gov/pubmed/19356803. Accessed 2013 October 11.
40. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM (2008) Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 14: 337-342. Available: http://dx.doi.org/10.1038/nm1715. Accessed 2013 June 18.
41. Hu X, Ivashkiv LB (2009) Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31: 539-550. Available: http://dx.doi.org/10.1016/j.immuni.2009.09.002. Accessed 2013 May 31.
42. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, et al. (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156: 5-7. Available: http://www.ncbi.nlm.nih.gov/pubmed/8598493. Accessed 2013 May 26.
43. Lazarevic V, Glimcher LH (2011) T-bet in disease. Nat Immunol 12: 597-606. Available: http://www.ncbi.nlm.nih.gov/pubmed/21685955. Accessed 2013 May 31.
44. Mathur AN, Chang H-C, Zisoulis DG, Stritesky GL, Yu Q, et al. (2007) Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178: 4901-4907. Available: http://www.ncbi.nlm.nih.gov/pubmed/17404271. Accessed 2013 July 31.
45. Williams CL, Schilling MM, Cho SH, Lee K, Wei M, et al. (2013) STAT4 and T-bet Are Required for the Plasticity of IFN-γ Expression across Th2 Ontogeny and Influence Changes in Ifng Promoter DNA Methylation. J Immunol 191: 678-687. Available: http://www.jimmunol.org/content/191/2/678.full. Accessed 2013 July 31.
46. Wang KS (2001) Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation. Blood 97: 3860-3866. Available: http://bloodjournal.hematologylibrary.org/content/97/12/3860.long. Accessed 3 July 2013.
47. Huang Y, Lei Y, Zhang H, Zhang M, Dayton A (2011) Interleukin-12 treatment down-regulates STAT4 and induces apoptosis with increasing ROS production in human natural killer cells. J Leukoc Biol 90: 87-97. Available: http://www.ncbi.nlm.nih.gov/pubmed/21543583. Accessed 2013 July 1.
48. Wei L, Vahedi G, Sun H-W, Watford WT, Takatori H, et al. (2010) Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 32: 840-851. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=2904651&tool=pmcentrez&rendertype=abstract. Accessed 2013 July 31.
49. Pham D, Yu Q, Walline CC, Muthukrishnan R, Blum JS, et al. (2013) Opposing Roles of STAT4 and Dnmt3a in Th1 Gene Regulation. J Immunol 191: 902-911. Available: http://www.ncbi.nlm.nih.gov/pubmed/23772023. Accessed 2013 July 31.
50. Van Rietschoten JG, Smits HH, van de Wetering D, Westland R, Verweij CL, et al. (2001) Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells. J Biol Chem 276: 34509-34516. Available: http://www.ncbi.nlm.nih.gov/pubmed/11438525. Accessed 2013 August 1.
51. Foletta VC (1996) Transcription factor AP-1, and the role of Fra-2. Immunol Cell Biol 74: 121-133. Available: http://dx.doi.org/10.1038/icb.1996.17. Accessed 2013 August 1.
52. Sutcliffe EL, Bunting KL, He YQ, Li J, Phetsouphanh C, et al. (2011) Chromatin-associated protein kinase C-h regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol Cell 41: 704-719. Available: http://dx.doi.org/10.1016/j.molcel.2011.02.030. Accessed 2013 August 16.
53. Korman BD, Kastner DL, Gregersen PK, Remmers EF (2008) STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 8: 398-403. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2562257&tool=pmcentrez&rendertype=abstract. Accessed 2013 July 31.